Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
6
pubmed:dateCreated
2005-6-3
pubmed:abstractText
1,2-GG intrastrand cross-links formed in DNA by the enantiomeric complexes [PtCl(2)(R,R-2,3-diaminobutane (DAB))] and [PtCl(2)(S,S-DAB)] were studied by biophysical methods. Molecular modeling revealed that structure of the cross-links formed at the TGGT sequence was affected by repulsion between the 5'-directed methyl group of the DAB ligand and the methyl group of the 5'-thymine of the TGGT fragment. Molecular dynamics simulations of the solvated platinated duplexes and our recent structural data indicated that the adduct of [PtCl(2)(R,R-DAB)] alleviated this repulsion by unwinding the TpG step, whereas the adduct of [PtCl(2)(S,S-DAB)] avoided the unfavorable methyl-methyl interaction by decreasing the kink angle. Electrophoretic retardation measurements on DNA duplexes containing 1,2-GG intrastrand cross-links of Pt(R,R-DAB)(2+) or Pt(S,S-DAB)(2+) at a CGGA site showed that in this sequence both enantiomers distorted the double helix to the identical extent similar to that found previously for the same sequence containing the cross-links of the parent antitumor cis-Pt(NH(3))(2)(2+) (cisplatin). In addition, the adducts showed similar affinities toward the high-mobility-group box 1 proteins. Hence, whereas the structural perturbation induced in DNA by 1,2-GG intrastrand cross-links of cisplatin does not depend largely on the bases flanking the cross-links, the perturbation related to GG cross-linking by bulkier platinum diamine derivatives does.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-10217454, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-10460158, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-10561579, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-10733979, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11040038, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11294645, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11303029, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11456962, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11514569, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11599959, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-11743736, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12031669, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12087174, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12102553, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12226099, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12467217, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12490708, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12534292, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-12744707, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-1463726, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-1518457, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-1566071, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-1868076, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-2174772, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-2191698, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-2397272, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-2482765, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-2619933, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-4048939, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-722741, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-7241508, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-7566180, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-8198530, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-8218235, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-8988007, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-9006117, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-9016685, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-9298962, http://linkedlifedata.com/resource/pubmed/commentcorrection/15805172-9649303
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jun
pubmed:issn
0006-3495
pubmed:author
pubmed:issnType
Print
pubmed:volume
88
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
4159-69
pubmed:dateRevised
2010-9-20
pubmed:meshHeading
pubmed:year
2005
pubmed:articleTitle
Chiral differentiation of DNA adducts formed by enantiomeric analogues of antitumor cisplatin is sequence-dependent.
pubmed:affiliation
Institute of Biophysics, Academy of Sciences of the Czech Republic, Brno.
pubmed:publicationType
Journal Article, In Vitro, Research Support, Non-U.S. Gov't